InvestorsHub Logo
Followers 155
Posts 2647
Boards Moderated 0
Alias Born 01/29/2004

Re: raja48185 post# 334055

Thursday, 10/28/2021 6:02:41 PM

Thursday, October 28, 2021 6:02:41 PM

Post# of 462563
Thank you. Good idea. In the comments section I just posted this note:

Interestingly, the study showed that “activation” of the sigma-1 receptor protein resulted in increased production of amyloid beta. Looks like that particular protein in neurons is a culprit in Alzheimer’s disease.

However, another sigma-1 receptor activator, Anavex Life Science’s blarcamesine (Anavex 2-73), does just the opposite. Its activation of the protein causes the protein to take on or resume modulation or facilitation of a number of homeostatic processes in the neuron. With those, the neuron functions normally, Alzheimer’s symptoms abate (or are prevented).

Scrutinize the schematics on Anavex sigma-1 receptor activation here:
https://www.anavex.com/sigmaceptor-explained

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News